Hypothetical cost savings associated with “observation” for low-risk prostate cancer

Posted on September 17, 2018 by Sitemaster

A newly published article in JAMA Oncology has reported hypothetical costs savings to Medicare of $320 million over a 3-year time frame if men of > 70 years with low-risk prostate cancer are simply “observed” as opposed being given immediate treated. … READ MORE …

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: , , , , , | Leave a comment »

10-year survival of conservatively managed prostate cancer patients with T1/T2 disease

Posted on September 16, 2009 by Sitemaster

Yet another study has added to the available data on the potential of conservative management for newly diagnosed prostate cancer patients. The current study reflects experience most specifically with the management of men of ≥ 65 years of age. … READ MORE …

Filed under: Management, Treatment | Tagged: , , | 4 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives